Needham Reiterates Inozyme Pharma (INZY) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on September 27, 2023, Needham reiterated coverage of Inozyme Pharma (NASDAQ:INZY) with a Buy recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1360504059-f133206201d847feb5c6cf30402df8dc.jpg "If I Reinvest My Dividends, Are They Still Taxable?")
:max_bytes(150000):strip_icc():format(jpeg)/Homer-Simpsons-words-of-wisdom-2884473d8fae4ec490b3aefc9f3ac9d4.jpg "Buy Pumpkins in October—and 4 More Money Lessons From Homer Simpson")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1726513942-3efe7d2e93e240bcaac9370f2dc113cf.jpg "What Is the Federal Employees Retirement System (FERS) and How Does It Work?")